These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 173573)

  • 41. Prevalence of netF-positive Clostridium perfringens in foals in southwestern Ontario.
    Finley A; Gohari IM; Parreira VR; Abrahams M; Staempfli HR; Prescott JF
    Can J Vet Res; 2016 Jul; 80(3):242-4. PubMed ID: 27408339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clostridium perfringens in faeces of healthy persons and diarrhoeal patients.
    Arora DR; Ichhpujani RL; Chugh TD
    Indian J Pathol Microbiol; 1981 Oct; 24(4):235-8. PubMed ID: 6279492
    [No Abstract]   [Full Text] [Related]  

  • 43. TOXIN PRODUCTION OF FAECAL STRAINS OF CLOSTRIDIUM WELCHII.
    PRICE DJ; SHOOTER RA
    Br Med J; 1964 Nov; 2(5418):1176-7. PubMed ID: 14190489
    [No Abstract]   [Full Text] [Related]  

  • 44. The effect of the continuous administration of diets containing tetracyclines and penicillin on the number of drug-resistant and drug-sensitive Clostridium welchii in the faeces of pigs and chickens.
    SMITH HW
    J Pathol Bacteriol; 1959 Jan; 77(1):79-93. PubMed ID: 13621336
    [No Abstract]   [Full Text] [Related]  

  • 45. Genetic variation among Clostridium perfringens isolated from food and faecal specimens in Lagos.
    Chukwu EE; Nwaokorie FO; Coker AO; Avila-Campos MJ; Ogunsola FT
    Microb Pathog; 2017 Oct; 111():232-237. PubMed ID: 28867621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of Clostridium perfringens strains isolated from Polish patients with suspected antibiotic-associated diarrhea.
    Pituch H; van den Braak N; van Belkum A; Van Leeuwen W; Obuch-Woszczatyński P; Łuczak M; Verbrugh H; Meisel-Mikołajczyk F; Martirosian G
    Med Sci Monit; 2002 Mar; 8(3):BR85-8. PubMed ID: 11887023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clostridium welchii infection of the pleural cavity.
    JOHNSON RW
    Edinb Med J; 1947 Aug; 54(8):447. PubMed ID: 20269371
    [No Abstract]   [Full Text] [Related]  

  • 48. The physiological function of nitrate reduction in Clostridium perfringens.
    Hasan SM; Hall JB
    J Gen Microbiol; 1975 Mar; 87(1):120-8. PubMed ID: 166143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clostridia in neonatal faeces.
    Kelsey MC; Vince AJ
    Lancet; 1979 Jul; 2(8133):100. PubMed ID: 87948
    [No Abstract]   [Full Text] [Related]  

  • 50. Clostridium perfringens (Cl. welchii) in the human gastro-intestinal tract.
    Collee JG
    Soc Appl Bacteriol Symp Ser; 1974; 3(0):205-19. PubMed ID: 4373836
    [No Abstract]   [Full Text] [Related]  

  • 51. Association between bacterial strain type and host biomarkers in Clostridium perfringens infected goats.
    Khan MA; Durrani AZ; Khan SB; Khan MA; Sheikh AA; Khan NU; Prince K; Ullah N; Khan AU
    Microb Pathog; 2017 Nov; 112():254-258. PubMed ID: 28963012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Cl. welchii as a potential cause of food poisoning].
    Seligman R
    Harefuah; 1971 Dec; 81(11):556-9. PubMed ID: 4335191
    [No Abstract]   [Full Text] [Related]  

  • 53. "In vivo" and "in vitro" antagonism exerted by two anaerobic strains against strains of clostridium perfringens.
    Yurdusev N; Ladire M; Ducluzeau R; Raibaud P
    Prog Clin Biol Res; 1985; 181():171-4. PubMed ID: 2862639
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pathogenicity of various toxinogenic types of Clostridium perfringens administered by mouth to axenic and holoxenic mice].
    Hudault S; Bridonneau C; Raibaud P
    Ann Microbiol (Paris); 1983; 134B(2):277-83. PubMed ID: 6316828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of interferon on tumor forming ability of Walker carcinosarcoma 256 cells and secretion of exo-toxin by the bacillus, Clostridium welchii (type C).
    Babbar OP; Singh DP; Bajpai SK
    Indian J Exp Biol; 1973 May; 11(3):199-206. PubMed ID: 4361113
    [No Abstract]   [Full Text] [Related]  

  • 56. Diarrhoea and simultaneous excretion of Clostridium difficile cytotoxin and C perfringens enterotoxin.
    Borriello SP; Welch AR; Larson HE; Barclay F
    Lancet; 1984 Nov; 2(8413):1218. PubMed ID: 6150266
    [No Abstract]   [Full Text] [Related]  

  • 57. Clostridium welchii corneal ulcer--a case report.
    Majekodunmi S; Odugbemi T
    Can J Ophthalmol; 1975 Apr; 10(2):290-2. PubMed ID: 164996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toxinotyping of Clostridium perfringens fecal isolates of reintroduced Père David's deer (Elaphurus davidianus) in China.
    Qiu H; Chen F; Leng X; Fei R; Wang L
    J Wildl Dis; 2014 Oct; 50(4):942-5. PubMed ID: 25050802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolic conversion of 3-methyl-5-ethyl-5-phenyl hydantoin (mesantoin) and of 5-ethyl-5-phenyl hydantoin (nirvanol) to 5 - ethyl -5- (p-hydroxyphenyl) hydantoin.
    BUTLER TC
    J Pharmacol Exp Ther; 1956 Jun; 117(2):160-5. PubMed ID: 13332557
    [No Abstract]   [Full Text] [Related]  

  • 60. Haemolytic activity of the alpha and theta toxins of Clostridium welchii.
    Schulze JA; Nakamura M
    J Hyg (Lond); 1969 Mar; 67(1):163-74. PubMed ID: 4322822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.